使用5M框架推进对心力衰竭的衰老反应性护理,减少喷射分数
Abigail Latimer1, Debra K Moser2, Jia-Rong Wu2
1College of Social Work, University of Kentucky, Lexington, KY, 40506, USA.
Clinical interventions in aging
|March 25, 2025
概括
患有心力衰竭的老年人面临复杂的护理需求. 5M模型提供了一种整体方法,以有效地管理这些挑战.
科学领域:
- 老年病的医生 老年病的医生
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 人口老龄化增加了管理慢性疾病的复杂性,例如心力衰竭与减少喷射率 (HFrEF).
- 高频率心脏病发作带来了独特的挑战,包括不可预测的疾病轨迹,突然心脏病死亡风险和复杂的治疗要求.
- 在老年人中管理HFrEF进一步复杂化的是并发症,财务毒性,心理健康问题和错误的护理偏好.
研究的目的:
- 提出5Ms模型作为优化HFrEF老年人护理的框架.
- 突出5M模型的整体方法,以解决这一患者群体的多方面的需求.
主要方法:
- 这是一个叙事评论.
- 在HFrEF护理的背景下,讨论了5Ms模型 (多复杂性,思想,流动性,药物和最重要的事情).
- 考虑了5Ms模型在其他医学领域的现有应用.
主要成果:
- 5Ms模型为HFrEF提供了一种结构化,整体的治疗方法.
- 它涉及到影响HFrEF老年人的关键领域:整体复杂性,精神健康,身体功能,药物管理和以患者为中心的目标.
- 这种模式可以指导全方位的管理,改善与患者价值观的护理对齐.
结论:
- 5Ms模型提供了一个有价值的框架,用于改进高FrEF的老年人综合护理.
- 实施这种模式可以导致更个性化和更有效的管理策略.
- 进一步的研究可能会探索5Ms模型对HFrEF患者临床结果的直接影响.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.4K
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.3K
相关概念视频
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:26Heart Failure Drugs: Inotropic Agents
476
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
476
01:22Heart Failure Drugs: β-Blockers
299
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
299
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
354
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
354
01:22Heart Failure Drugs: Diuretics
309
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
309
01:17Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K